ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Greenwich LifeSciences Inc

Greenwich LifeSciences Inc (GLSI)

14.345
0.025
( 0.17% )
更新日時: 03:01:14

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
14.345
買値
14.29
売値
14.52
出来高
30,608
14.14 日の範囲 14.98
7.58 52 週間の範囲 21.44
時価総額
前日終値
14.32
始値
14.57
最終取引時間
02:59:32
財務取引量
US$ 445,600
VWAP
14.5583
平均取引量 (3 か月)
33,439
発行済株式数
13,144,653
配当利回り
-
PER
-21.20
1 株当たり利益 (EPS)
-0.68
歳入
-
純利益
-8.89M

Greenwich LifeSciences Inc について

Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variet... Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in most breast cancers at low, intermediate, and high or overexpressor levels. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Greenwich LifeSciences Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker GLSI. The last closing price for Greenwich LifeSciences was US$14.32. Over the last year, Greenwich LifeSciences shares have traded in a share price range of US$ 7.58 to US$ 21.44.

Greenwich LifeSciences currently has 13,144,653 shares in issue. The market capitalisation of Greenwich LifeSciences is US$188.23 million. Greenwich LifeSciences has a price to earnings ratio (PE ratio) of -21.20.

GLSI 最新ニュース

Greenwich LifeSciences Provides Update on Expansion of Flamingo-01 into Spain

STAFFORD, Texas, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical...

Greenwich LifeSciences Set to Join Russell 2000 Index Again

STAFFORD, Texas, June 26, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical...

Greenwich LifeSciences Announces $2.5 Million Private Placement

STAFFORD, Texas, June 14, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company" or "Greenwich"), a clinical-stage biopharmaceutical company focused on its Phase III...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.535-3.5954301075314.8815.514.143932114.8724963CS
4-0.015-0.10445682451314.3616.513.13394013114.48561218CS
12-2.475-14.714625445916.8217.188212.753343914.76791626CS
26-6.195-30.160662122720.5421.4411.3753422314.98992361CS
525.65565.07479861918.6921.447.583244713.83563586CS
156-26.955-65.266343825741.341.426.82416283513.81633166CS
2609.345186.951283.26213145533.48148062CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
UXINUxin Ltd
US$ 5.055
(78.62%)
20.39M
CNEYCN Energy Group Inc
US$ 0.982
(69.34%)
206.22M
ONCOOnconetix Inc
US$ 5.3557
(59.61%)
32.07M
JFU9F Inc
US$ 1.80
(37.40%)
183.35k
TCTMTCTM Kids IT Education Inc
US$ 1.30
(36.84%)
7.86M
EDBLEdible Garden AG Inc
US$ 0.2789
(-40.05%)
4.46M
ICGIntchains Group Ltd
US$ 5.15
(-39.27%)
2.21M
NVNOenVVeno Medical Corporation
US$ 3.395
(-24.56%)
1.85M
JNVRJanover Inc
US$ 0.50
(-24.13%)
55.28k
TBIOTelesis Bio Inc
US$ 3.05
(-23.56%)
1.18M
XPONExpion360 Inc
US$ 0.0784
(21.74%)
227.37M
CNEYCN Energy Group Inc
US$ 0.982
(69.34%)
206.22M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.1526
(11.71%)
192.35M
NVDANVIDIA Corporation
US$ 120.68
(-2.71%)
174.42M
SQQQProShares UltraPro Short QQQ
US$ 7.405
(1.16%)
96.03M

GLSI Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock